Hydrocodone/Homatropine Tablet
Hydrocodone/Homatropine is a compounded formulation containing Hydrocodone, Homatropine, prepared by Mixlab for veterinary use. Available by prescription.
This compounded formulation combines hydrocodone, an opioid, with homatropine, an anticholinergic — two different drug classes. In compounding practice, clinicians may consider a combination like this for a multi-targeted approach. Your veterinarian determines whether it is appropriate based on your animal's diagnostic findings.
This description reflects the general pharmacology of the active ingredient's drug class; your veterinarian determines whether this approach is appropriate for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, hydrocodone manages the cough center in the brain, while homatropine manage localized respiratory secretions and digestive comfort. Commonly observed effects include behavioral shifts such as sedation, lethargy and localized changes like dry mouth or constipation. Because it influences the central nervous system, your veterinarian will monitor for observational signs of sensitivity. Owners should monitor for significant changes in activity levels and contact their veterinarian promptly with any concerns regarding the patient's response to the medication.
Yes. Hydrocodone and homatropine is a prescription medication and a controlled substance. Mixlab verifies all legal requirements before any medication is prepared.
Yes. Mixlab specializes in compounding the combination of hydrocodone and homatropine into customized flavored formats, such as oral liquids, to support easier administration for your pet.
Veterinarians discuss this combination because it acts on the brain to manage the frequency of coughing while also managing localized airway secretions. This provides a method for managing comfort in pets with chronic lung challenges.
Commonly observed effects include drowsiness, dry mouth and constipation. Your veterinarian will provide guidance on monitoring your pet's energy and appetite during the course of management.
This combination is typically used with caution in dogs with certain heart or lung conditions. Your veterinarian will determine if this management approach is appropriate for your individual pet’s health status.
